Retasturtide is a recently introduced novel GLP-1 receptor agonist demonstrating promising results in the management of type 2 diabetes. This artificial peptide duplicates the actions of naturally produced GLP-1, a hormone that plays a crucial role in managing blood glucose levels. By activating GLP-1 receptors in the pancreas, Retasturtide promot